[1]
A. Zabeti Touchaei, “Trastuzumab Resistance in HER2-Positive Gastric Cancer: From Molecular Mechanisms to Precision Therapeutics”, J Can Biomol Therap, vol. 2, no. 4, pp. 1–10, Oct. 2025.